Page last updated: 2024-08-17

levodopa and ALS - Amyotrophic Lateral Sclerosis

levodopa has been researched along with ALS - Amyotrophic Lateral Sclerosis in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19904 (26.67)18.7374
1990's1 (6.67)18.2507
2000's8 (53.33)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Leitinger, G; Maurer, C; Radulović, S; Sunkara, S1
Kim, BJ; Kim, JS; Kim, KK; Kim, SM; Lee, MC; Lim, YM; Park, HK1
Aquilonius, SM; Askmark, H; Gomes-Trolin, C; Nygren, I1
Ferrannini, E; Fraddosio, A; Iliceto, G; Lamberti, S; Maggio, F; Palagano, G; Russo, I; Serlenga, L; Zoccolella, S1
Foster, HD; Hoffer, A1
Fahn, S1
Hideyama, T; Kwak, S; Momose, T; Shimizu, J; Tsuji, S1
Kaneda, D; Oyanagi, K; Shintaku, M1
Adeva-Bartolomé, T; Alonso-Navarro, H; Jiménez-Jiménez, FJ; Ruiz-Ezquerro, JJ1
Johnson, RT; Price, DL1
Matsuoka, H; Mizoguchi, K; Nishimura, Y; Obi, T; Takatsu, M1
Danysz, W1
Gerstenbrand, F; Gründig, E; Weiss, J1
Brody, JA; Kurland, LT; Stanhope, JM1
Akiguchi, I; Itoh, H; Kameyama, M; Nakamura, S; Yamao, S1

Reviews

4 review(s) available for levodopa and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
    International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine

2021
ALS lessons learned from other neurological diseases. Parkinson's disease.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2004, Volume: 5 Suppl 1

    Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Behavioral Symptoms; Coenzymes; Controlled Clinical Trials as Topic; Disease Progression; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Ubiquinone

2004
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:5

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Humans; Levodopa; Nerve Growth Factor; Neuroprotective Agents; Nicotine; Parkinson Disease

2001
Patterns of Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia on Guam.
    Contemporary neurology series, 1975, Volume: 12

    Topics: Adult; Aged; Amines; Amyotrophic Lateral Sclerosis; Autopsy; Dementia; Demography; Environmental Pollutants; Ethnicity; Female; Gene Frequency; Guam; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Toxins, Biological

1975

Trials

1 trial(s) available for levodopa and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Increased red blood cell polyamines in ALS and Parkinson's disease.
    Experimental neurology, 2002, Volume: 177, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Biogenic Polyamines; Erythrocytes; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Putrescine; Spermidine; Spermine; Time Factors

2002

Other Studies

10 other study(ies) available for levodopa and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism.
    Journal of the neurological sciences, 2011, Feb-15, Volume: 301, Issue:1-2

    Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Corpus Striatum; Fluorine Radioisotopes; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Radiopharmaceuticals; Substantia Nigra; Tremor; Tropanes

2011
ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2

    Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Dementia; Female; Humans; Levodopa; Male; Parkinsonian Disorders

2002
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
    Medical hypotheses, 2004, Volume: 62, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Hallucinations; Humans; Levodopa; Multiple Sclerosis; Oxidative Stress; Parkinson Disease; Parkinson Disease, Postencephalitic; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Vitamin B Complex

2004
A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
    Archives of neurology, 2006, Volume: 63, Issue:12

    Topics: Aged; Amyotrophic Lateral Sclerosis; Cerebrovascular Circulation; Female; Humans; Levodopa; Male; Middle Aged; Motor Neuron Disease; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Spiperone; Substantia Nigra; Tomography, Emission-Computed, Single-Photon

2006
Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2007, Volume: 27, Issue:3

    Topics: Aged; Amyotrophic Lateral Sclerosis; Autopsy; Dementia; Diagnosis, Differential; Dopamine Agents; Fatal Outcome; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra

2007
[Association between amytrophic lateral sclerosis and Parkinson's disease].
    Medicina clinica, 2007, Oct-06, Volume: 129, Issue:12

    Topics: Aged; Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Cabergoline; Carbidopa; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Riluzole; Time Factors; Tomography, X-Ray Computed

2007
Chronic neurological diseases: their societal burdens and potential solutions.
    Journal of chronic diseases, 1980, Volume: 33, Issue:3

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Ataxia; Axons; Brain Diseases; Cerebral Cortex; Chronic Disease; Dopamine; Humans; Huntington Disease; Immunoglobulin G; Levodopa; Motor Neurons; Multiple Sclerosis; Parkinson Disease

1980
Muscle cramp as the result of impaired GABA function--an electrophysiological and pharmacological observation.
    Muscle & nerve, 1993, Volume: 16, Issue:11

    Topics: Amyotrophic Lateral Sclerosis; Baclofen; Clomipramine; Diazepam; Electric Stimulation; Evoked Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Levodopa; Lidocaine; Male; Middle Aged; Motor Neurons; Muscle Cramp; Muscular Atrophy, Spinal; Nerve Block; Neural Conduction; Sensory Thresholds; Ulnar Nerve

1993
[The activity of aminotransferases in serum and cerebrospinal fluid in neurological diseases (author's transl)].
    Wiener klinische Wochenschrift, 1975, Dec-12, Volume: 87, Issue:23

    Topics: Alanine Transaminase; Amyotrophic Lateral Sclerosis; Aspartate Aminotransferases; Craniocerebral Trauma; Friedreich Ataxia; Guanidines; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease; Penicillins; Phenylketonurias; Transaminases

1975
[Levodopa therapy in a patient with ALS-dementia complex].
    Rinsho shinkeigaku = Clinical neurology, 1987, Volume: 27, Issue:9

    Topics: Amyotrophic Lateral Sclerosis; Dementia; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged

1987